BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15047604)

  • 1. Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors.
    Kwon HS; Huang B; Unterman TG; Harris RA
    Diabetes; 2004 Apr; 53(4):899-910. PubMed ID: 15047604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
    Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA
    Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.
    Daitoku H; Yamagata K; Matsuzaki H; Hatta M; Fukamizu A
    Diabetes; 2003 Mar; 52(3):642-9. PubMed ID: 12606503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity.
    Schmoll D; Walker KS; Alessi DR; Grempler R; Burchell A; Guo S; Walther R; Unterman TG
    J Biol Chem; 2000 Nov; 275(46):36324-33. PubMed ID: 10960473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.
    Guo S; Rena G; Cichy S; He X; Cohen P; Unterman T
    J Biol Chem; 1999 Jun; 274(24):17184-92. PubMed ID: 10358076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin.
    Connaughton S; Chowdhury F; Attia RR; Song S; Zhang Y; Elam MB; Cook GA; Park EA
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):159-67. PubMed ID: 19703515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
    Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin.
    Huang B; Wu P; Bowker-Kinley MM; Harris RA
    Diabetes; 2002 Feb; 51(2):276-83. PubMed ID: 11812733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increase in cardiac pyruvate dehydrogenase kinase-4 after short-term dexamethasone is controlled by an Akt-p38-forkhead box other factor-1 signaling axis.
    Puthanveetil P; Wang Y; Wang F; Kim MS; Abrahani A; Rodrigues B
    Endocrinology; 2010 May; 151(5):2306-18. PubMed ID: 20181797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
    Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
    Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBPbeta). Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta.
    Guo S; Cichy SB; He X; Yang Q; Ragland M; Ghosh AK; Johnson PF; Unterman TG
    J Biol Chem; 2001 Mar; 276(11):8516-23. PubMed ID: 11116148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway.
    Roth U; Curth K; Unterman TG; Kietzmann T
    J Biol Chem; 2004 Jan; 279(4):2623-31. PubMed ID: 14612449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation.
    Furuyama T; Kitayama K; Yamashita H; Mori N
    Biochem J; 2003 Oct; 375(Pt 2):365-71. PubMed ID: 12820900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics.
    Jacobs FM; van der Heide LP; Wijchers PJ; Burbach JP; Hoekman MF; Smidt MP
    J Biol Chem; 2003 Sep; 278(38):35959-67. PubMed ID: 12857750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways.
    Cahill CM; Tzivion G; Nasrin N; Ogg S; Dore J; Ruvkun G; Alexander-Bridges M
    J Biol Chem; 2001 Apr; 276(16):13402-10. PubMed ID: 11124266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression.
    Zhang Y; Ma K; Sadana P; Chowdhury F; Gaillard S; Wang F; McDonnell DP; Unterman TG; Elam MB; Park EA
    J Biol Chem; 2006 Dec; 281(52):39897-906. PubMed ID: 17079227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients.
    Kino T; De Martino MU; Charmandari E; Ichijo T; Outas T; Chrousos GP
    Diabetes; 2005 Jan; 54(1):23-31. PubMed ID: 15616007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
    Lochhead PA; Coghlan M; Rice SQ; Sutherland C
    Diabetes; 2001 May; 50(5):937-46. PubMed ID: 11334436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) binding and the inhibition of basal glucose-6-phosphatase catalytic subunit gene transcription by insulin.
    Onuma H; Vander Kooi BT; Boustead JN; Oeser JK; O'Brien RM
    Mol Endocrinol; 2006 Nov; 20(11):2831-47. PubMed ID: 16840535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences.
    Yeagley D; Guo S; Unterman T; Quinn PG
    J Biol Chem; 2001 Sep; 276(36):33705-10. PubMed ID: 11445561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.